|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments in real estate, at cost | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Investments in real estate, net | ||||||||||||||||||||
| Investments in real estate: | ||||||||||||||||||||
| Investments in real estate, at cost | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Investments in real estate, net | ||||||||||||||||||||
| Real estate, held for sale | ||||||||||||||||||||
| Investments in real estate under development | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted Cash | ||||||||||||||||||||
| Investments in unconsolidated real estate entities | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Derivative assets | ||||||||||||||||||||
| Intangible assets, net of accumulated amortization of $335 and $3,257, respectively | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY: | ||||||||||||||||||||
| Indebtedness, net | ||||||||||||||||||||
| Indebtedness associated with real estate held for sale | ||||||||||||||||||||
| Indebtedness, net | ||||||||||||||||||||
| Debt Not Associated with Real Estate Held for Sale | ||||||||||||||||||||
| Debt Associated with Real Estate Held for Sale | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Other Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value; 50,000,000 shares authorized, 0 and 0 shares issued and outstanding, respectively | ||||||||||||||||||||
| Common stock, $0.01 par value; 500,000,000 shares authorized, 235,742,658 and 237,234,750 shares issued and outstanding, including 428,346 and 382,337 unvested restricted common share awards, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities and Equity |
Loading...
